Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Folli

Showing results (61-70 of 166) with videos related to

Pageof 17
Sort By:
The Journal of Clinical Psychiatry|May 20, 2024
Effect of Time From Onset of Major Depressive Disorder on the Therapeutic Response to Esmethadone (REL-1017)Clotilde Guidetti, Sara De Martin, Giulia Serra, et al.
Pharmacological Research|November 29, 2024
Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE-2 studyCesare Berra, Roberto Manfrini, Francesco Bifari, et al.
Andrologia|April 16, 2019
Early varicocelectomy by percutaneous scleroembolization improves seminiferous tubules spermatozoa release in the adolescent phase of testicular growthMario Mancini, Gianpaolo Carrafiello, Fabio Melchiorre, et al.
The Primary Care Companion for CNS Disorders|February 23, 2023
Subanalysis of Subjective Cognitive Measures From a Phase 2, Double-Blind, Randomized Trial of REL-1017 in Patients With Major Depressive DisorderClotilde Guidetti, Giulia Serra, Luca Pani, et al.
Acta Diabetologica|April 1, 2019
Hypoglycemia and hyperglycemia are risk factors for falls in the hospital populationCesare Berra, Francesco De Fazio, Elena Azzolini, et al.
Diabetes Care|October 27, 2005
Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled studyAntonio E Pontiroli, Franco Folli, Michele Paganelli, et al.
Pharmacological Research|February 3, 2025
Reply to the letter comment of Su Boon Yong MD, PhD and colleagues to: Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE- 2 studyCesare Berra, Roberto Manfrini, Francesco Bifari, et al.
Journal of Hepatology|September 16, 2003
Regulation of ERK/JNK/p70S6K in two rat models of liver injury and fibrosisGianluca Svegliati-Baroni, Francesco Ridolfi, Zaira Caradonna, et al.
The Journal of Clinical Endocrinology and Metabolism|April 28, 2005
Circulating leptin correlates with left ventricular mass in morbid (grade III) obesity before and after weight loss induced by bariatric surgery: a potential role for leptin in mediating human left ventricular hypertrophyLucia Perego, Pierluigi Pizzocri, Domenico Corradi, et al.
Plos One|September 27, 2013
Energy expenditure evaluation in humans and non-human primates by SenseWear Armband. Validation of energy expenditure evaluation by SenseWear Armband by direct comparison with indirect calorimetryFrancesca Casiraghi, Raweewan Lertwattanarak, Livio Luzi, et al.
Pageof 17

Showing results (61-70 of 166) with videos related to

Sort By:
Pageof 17
The Journal of Clinical Psychiatry|May 20, 2024
Effect of Time From Onset of Major Depressive Disorder on the Therapeutic Response to Esmethadone (REL-1017)Clotilde Guidetti, Sara De Martin, Giulia Serra, et al.
Pharmacological Research|November 29, 2024
Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE-2 studyCesare Berra, Roberto Manfrini, Francesco Bifari, et al.
Andrologia|April 16, 2019
Early varicocelectomy by percutaneous scleroembolization improves seminiferous tubules spermatozoa release in the adolescent phase of testicular growthMario Mancini, Gianpaolo Carrafiello, Fabio Melchiorre, et al.
The Primary Care Companion for CNS Disorders|February 23, 2023
Subanalysis of Subjective Cognitive Measures From a Phase 2, Double-Blind, Randomized Trial of REL-1017 in Patients With Major Depressive DisorderClotilde Guidetti, Giulia Serra, Luca Pani, et al.
Acta Diabetologica|April 1, 2019
Hypoglycemia and hyperglycemia are risk factors for falls in the hospital populationCesare Berra, Francesco De Fazio, Elena Azzolini, et al.
Diabetes Care|October 27, 2005
Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled studyAntonio E Pontiroli, Franco Folli, Michele Paganelli, et al.
Pharmacological Research|February 3, 2025
Reply to the letter comment of Su Boon Yong MD, PhD and colleagues to: Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE- 2 studyCesare Berra, Roberto Manfrini, Francesco Bifari, et al.
Journal of Hepatology|September 16, 2003
Regulation of ERK/JNK/p70S6K in two rat models of liver injury and fibrosisGianluca Svegliati-Baroni, Francesco Ridolfi, Zaira Caradonna, et al.
The Journal of Clinical Endocrinology and Metabolism|April 28, 2005
Circulating leptin correlates with left ventricular mass in morbid (grade III) obesity before and after weight loss induced by bariatric surgery: a potential role for leptin in mediating human left ventricular hypertrophyLucia Perego, Pierluigi Pizzocri, Domenico Corradi, et al.
Plos One|September 27, 2013
Energy expenditure evaluation in humans and non-human primates by SenseWear Armband. Validation of energy expenditure evaluation by SenseWear Armband by direct comparison with indirect calorimetryFrancesca Casiraghi, Raweewan Lertwattanarak, Livio Luzi, et al.
Pageof 17